Claritev (CTEV) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SOPHiA GENETICS SA (SOPH) has outperformed Claritev (CTEV) over the past year, gaining 71.9% versus a loss of 55.0%. Over five years, SOPH leads with a -55.6% price change compared with -86.5% for CTEV. SOPHiA GENETICS SA is the larger company by market cap ($608.7 million vs $424.2 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTEV | SOPH |
|---|---|---|
| Share price | $25.03 | $7.15 |
| Market cap | $424.20M | $608.66M |
| 1-day change | +3.90% | -3.12% |
| YTD return | -41.45% | +53.10% |
| 1-year return | -55.01% | +71.88% |
| 5-year return | -86.51% | -55.59% |
| Forward P/E | 3.41 | — |
| EPS (TTM) | $-17.66 | $-1.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $73.68 | $8.98 |
| 52-week low | $11.50 | $3.75 |
| Distance from 52-week high | -66.03% | -20.38% |
| Analyst consensus | buy | none |
| Avg. price target upside | +83.78% | +36.36% |
| Average volume | 133.69K | 545.93K |
| Shares outstanding | 16.95M | 85.13M |
| Employees | 3,000 | 415 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SOPH has outperformed CTEV by 126.9 percentage points over the past year.
About Claritev
CTEV stock →Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
Healthcare · Health Information Services · 3,000 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Healthcare · Health Information Services · 415 employees
CTEV vs SOPH FAQ
Which is bigger, Claritev or SOPHiA GENETICS SA?
SOPHiA GENETICS SA (SOPH) is larger, with a market capitalization of $608.66M compared with $424.20M for Claritev (CTEV).
Which stock has performed better over the past year, CTEV or SOPH?
SOPH returned +71.88% over the past 12 months, compared with -55.01% for CTEV (price return, excluding dividends). Past performance does not predict future results.
Are Claritev and SOPHiA GENETICS SA in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.